Kallioniemi O

Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma.

Roos-Mattila M, Kallio P, Luck TJ, ..., Pietiäinen VM, Seppänen HE

Commun Biol 7 (1) 1355 [2024-10-20; online 2024-10-20]

Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts.

Olesinski EA, Bhatia KS, Wang C, ..., Letai A, Bhatt S

Blood Cancer Discov 5 (3) 180-201 [2024-05-01; online 2024-03-05]

Therapeutic opportunity of phosphodiesterase 3A modulators in myxoid liposarcomas

Toivanen K, Kilpinen S, Ojala K, ..., Böhling T, Sihto H

- - (-) - [2022-12-09; online 2022-12-09]

Image-based & machine learning-guided multiplexed serology test for SARS-CoV-2

Pietiäinen V, Polso M, Migh E, ..., Horvath P, Hepojoki J

- - (-) - [2022-09-09; online 2022-09-09]

Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention.

Raivola J, Dini A, Karvonen H, ..., Murumägi A, Ungureanu D

Cell Death Dis 13 (8) 714 [2022-08-17; online 2022-08-17]

Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer.

Pellinen T, Sandeman K, Blom S, ..., Rannikko A, Mirtti T

Cancer Res Commun 2 (3) 172-181 [2022-03-00; online 2022-03-21]

Multiomics and digital monitoring during lifestyle changes reveal independent dimensions of human biology and health

Marabita F, James T, Karhu A, ..., Sallinen R, Kallioniemi O

- - (-) - [2020-11-12; online 2020-11-12]

KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia.

Malani D, Yadav B, Kumar A, ..., Murumägi A, Kallioniemi O

Leukemia 34 (10) 2780-2784 [2020-10-00; online 2020-07-17]

Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML.

Brück O, Blom S, Dufva O, ..., Pellinen T, Mustjoki S

Leukemia 32 (7) 1643-1656 [2018-07-00; online 2018-06-20]

ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer.

Pellinen T, Blom S, Sánchez S, ..., Kallioniemi O, Del Pozo MA

Sci Rep 8 (1) 2338 [2018-02-05; online 2018-02-05]

Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis.

Blom S, Paavolainen L, Bychkov D, ..., Kallioniemi O, Pellinen T

Sci Rep 7 (1) 15580 [2017-11-14; online 2017-11-14]

Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia.

Ojamies PN, Kontro M, Edgren H, ..., Wolf M, Kallioniemi O

Leukemia 31 (5) 1048-1058 [2017-05-00; online 2016-10-31]

The impact of low-frequency and rare variants on lipid levels.

Surakka I, Horikoshi M, Mägi R, ..., Ripatti S, ENGAGE Consortium

Nat. Genet. 47 (6) 589-597 [2015-06-00; online 2015-05-11]